Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-FIXa antibody variable domains fused with a scFv from an anti-FX antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.
There are currently no customer reviews or questions for Recombinant Anti-FIXa x Anti-FX Bispecific Antibody (Tandem scFv) (BSFV-162). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS